Syncom Healthcare has informed that the meeting of the Board of Directors of the Company is scheduled to be held on February 14, 2017, to consider and take on record the unaudited financial results of the Company for the quarter and nine months ended December 31, 2016 (Q3). Further, as per the ‘code of conduct’ formed under Securities and Exchange Board of India (Prohibition of Insider Trading ) Regulations ,2015, the trading window will be closed from 7th February 2017 till forty eight hours after the declaration of the results for Directors, KMP, officers and Designated employees and their immediate relatives.
The above information is a part of company’s filings submitted to BSE.